|  | Number (n = 139) |  |  | Number (n = 139) |
---|---|---|---|---|---|
Result | Positive | 1 (0.72%) | Radiation Technique | 3D-CRT | 30 (21.6%) |
 | Negative | 138 (99.3%) |  | VMAT | 83 (59.7%) |
 |  |  |  | SRS/SRT/SBRT | 18 (13.0%) |
Age | < 40 | 9 (6.5%) |  | Brachytherapy | 5 (3.6%) |
 | 40–49 | 15 (10.8%) |  | Others | 3 (2.2%) |
 | 50–59 | 32 (23.0%) |  |  |  |
 | 60–69 | 25 (18.0%) | Entity | Brain | 13 (9.4%) |
 | > 70 | 58 (41.7%) |  | Head & Neck | 11 (8.0%) |
 |  |  |  | Breast | 36 (25.9%) |
Gender | Male | 65 (46.8%) | Â | Gynaecological | 12 (8.6%) |
 | Female | 74 (53.2%) |  | Lung | 24 (17.3%) |
 |  |  |  | Gastrointestinal | 12 (8.6%) |
 |  |  |  | Bladder | 2 (1.4%) |
Intention | Curative | 95 (68.3%) | Â | Prostate | 17 (12.2%) |
 | adjuvant | 59 (42.4%) |  | Lymphoma | 3 (2.2%) |
 | definitive | 36 (25.9%) |  | Sarcoma | 4 (2.9%) |
 | Palliative | 44 (31.7%) |  | Melanoma | 4 (2.9%) |
 |  |  |  | Others | 6 (4.3%) |